menu
    • menu

    Company profile for Sirtex Medical

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sirtex Medical is a global healthcare business with offices in the US, Australia, Germany and Singapore, working to improve outcomes in people with cancer. Our current lead product is a targeted radiation therapy for liver tumours called SIR-Spheres® Y-90 resin microspheres. More than 100,000 doses have been supplied to treat patients with liver cancer at more than 1,300 medical centres in over 50 countries.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sirtex MedicalUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    300 Unicorn Park Drive, Woburn MA 01801
    Telephone
    Telephone
    +1-888-474-7839
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sirtex.com/au/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sirtex-medical-limited/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/SirtexMedical

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sirtex Medical secures positive approval of SIR-Spheres Y-90 resin microspheres
    Sirtex Medical secures positive approval of SIR-Spheres Y-90 resin microspheres

    15 Sep 2022

    // APNEWS

    https://apnews.com/article/health-brazil-cancer-1a54a52cc49ce2e00a71cc5ff4499bcf

    APNEWS
    15 Sep 2022
    Share Share
    Sirtex Medical, Grand Pharma receives NDA approval of SIR-Spheres Y-90 resin
    Sirtex Medical, Grand Pharma receives NDA approval of SIR-Spheres Y-90 resin

    09 Feb 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sirtex-medical-and-grand-pharmaceutical-group-limited-receive-nda-approval-of-sir-spheres-y-90-resin-microspheres-in-china-from-the-national-medical-products-administration-301478731.html

    PRNEWSWIRE
    09 Feb 2022
    Share Share
    Sirtex Medical successful first administration of SIR-Spheres Y-90 resin
    Sirtex Medical successful first administration of SIR-Spheres Y-90 resin

    11 Oct 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sirtex-medical-and-china-grand-pharmaceutical-announce-successful-first-administration-of-sir-spheres-y-90-resin-microspheres-in-china-301396651.html

    PRNEWSWIRE
    11 Oct 2021
    Share Share
    Sirtex Medical announces new SIR-Spheres® DOORwaY-90 Study
    Sirtex Medical announces new SIR-Spheres® DOORwaY-90 Study

    22 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sirtex-medical-announces-new-sir-spheres-doorway-90-study-the-first-prospective-multicenter-us-based-trial-for-registration-as-first-line-treatment-for-hepatocellular-carcinoma-301252379.html

    PRNEWSWIRE
    22 Mar 2021
    Share Share
    Sirtex Medical receives positive recommendation from (NICE)
    Sirtex Medical receives positive recommendation from (NICE)

    26 Feb 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sirtex-medical-receives-positive-recommendation-from-national-institute-for-health-and-care-excellence-nice-for-selective-internal-radiation-therapy-sirt-using-sir-spheres-301236484.html

    PRNEWSWIRE
    26 Feb 2021
    Share Share
    CIRT-EU Registry for SIR-Spheres® Therapy presented at CIRSE 2020 Summit
    CIRT-EU Registry for SIR-Spheres® Therapy presented at CIRSE 2020 Summit

    15 Sep 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cirt-eu-registry-for-sir-spheres-therapy-presented-at-cirse-2020-summit-301130738.html

    PRNEWSWIRE
    15 Sep 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search